Aiforia
Summary active Updated Aug 3, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
About
Aiforia is a Helsinki-based life-science technology company that develops deep-learning AI software for digital pathology, helping pathologists analyze ultra-high-resolution biopsy images to detect tumors and diagnose disease 12. The company is the leading European provider of CE-IVD marked AI-powered solutions for digital pathology and operates subsidiaries in the United States and France 1. Aiforia’s platform accelerates and standardizes tissue analysis workflows used in clinical diagnostics, drug discovery, and pre-clinical research 1.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-08-03 | Venture Debt | €20M | European Investment Bank | — 12 |
The financing is structured as venture debt under the European Commission’s InvestEU programme 12. According to disclosure filings, the €20M facility is drawn in three tranches subject to revenue milestones within 36 months of the binding agreement, with a three-year grace period, seven-year maturity, and synthetic warrants granted to the EIB 3. Proceeds will accelerate Aiforia’s product development for AI-powered cancer detection and expand its commercial operations 12.
What Investors Say
No independently sourced investor commentary quoted at press time.
What Founders Say
No independently sourced founder testimonials found at this time.
Sources
-
“Aiforia lands EU financing to develop AI-powered cancer detection,” European Investment Bank press release, August 2026. Accessed August 2026. https://www.eib.org/en/press/all/2026-268-aiforia-lands-eu-financing-to-develop-ai-powered-cancer-detection↩↩↩↩↩↩
-
“Helsinki-based Aiforia secures €20 million EIB financing to advance AI-powered cancer diagnostics,” EU-Startups, August 2026. Accessed August 2026. https://www.eu-startups.com/2026/08/helsinki-based-aiforia-secures-e20-million-eib-financing-to-advance-ai-powered-cancer-diagnostics/↩↩↩↩
-
“Aiforia Technologies Secures Potential €20M EIB Venture Debt,” WebDisclosure, June 17, 2026. Accessed August 2026. https://www.webdisclosure.com/article/aiforia-technologies-oyj-etr-aiforia-technologies-secures-potential-20m-eib-venture-debt-viqujTMUUtT↩